GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (NAS:NTRB) » Definitions » Ending Cash Position

NTRB (Nutriband) Ending Cash Position : $5.70 Mil (As of Oct. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Nutriband Ending Cash Position?

Nutriband's Ending Cash Position for the quarter that ended in Oct. 2024 was $5.70 Mil.

Nutriband's quarterly Ending Cash Position declined from Apr. 2024 ($8.35 Mil) to Jul. 2024 ($6.76 Mil) and declined from Jul. 2024 ($6.76 Mil) to Oct. 2024 ($5.70 Mil).

Nutriband's annual Ending Cash Position declined from Jan. 2022 ($4.89 Mil) to Jan. 2023 ($1.99 Mil) and declined from Jan. 2023 ($1.99 Mil) to Jan. 2024 ($0.49 Mil).


Nutriband Ending Cash Position Historical Data

The historical data trend for Nutriband's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband Ending Cash Position Chart

Nutriband Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 0.01 0.15 4.89 1.99 0.49

Nutriband Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 0.49 8.35 6.76 5.70

Nutriband Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nutriband's Ending Cash Position for the fiscal year that ended in Jan. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.986+-1.493
=0.49

Nutriband's Ending Cash Position for the quarter that ended in Oct. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=6.76+-1.062
=5.70


Nutriband Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nutriband's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband Business Description

Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Executives
Michael Davidov director 60 EAST 42 STREET, NEW YORK NY 10165
Serguei Melnik director, 10 percent owner, officer: Chief Financial Officer
Gareth Sheridan director, 10 percent owner, officer: CEO 6064 CENTRAL COLLEGE RD., NEW ALBANY OH 43054
Vitalie Botgros director, 10 percent owner, officer: Chairman of the BOD GREGERSTR 36B, FISHAMEND C4 2401